Lineage Cell Therapeutics (LCTX) Prepaid Assets (2016 - 2025)
Historic Prepaid Assets for Lineage Cell Therapeutics (LCTX) over the last 16 years, with Q3 2025 value amounting to $1.6 million.
- Lineage Cell Therapeutics' Prepaid Assets rose 2817.12% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 2817.12%. This contributed to the annual value of $2.6 million for FY2024, which is 1588.02% up from last year.
- According to the latest figures from Q3 2025, Lineage Cell Therapeutics' Prepaid Assets is $1.6 million, which was up 2817.12% from $1.3 million recorded in Q2 2025.
- Lineage Cell Therapeutics' 5-year Prepaid Assets high stood at $3.2 million for Q3 2021, and its period low was $1.3 million during Q3 2024.
- In the last 5 years, Lineage Cell Therapeutics' Prepaid Assets had a median value of $1.9 million in 2025 and averaged $2.0 million.
- In the last 5 years, Lineage Cell Therapeutics' Prepaid Assets surged by 12355.02% in 2021 and then crashed by 4854.29% in 2022.
- Quarter analysis of 5 years shows Lineage Cell Therapeutics' Prepaid Assets stood at $2.4 million in 2021, then fell by 22.25% to $1.8 million in 2022, then grew by 20.57% to $2.2 million in 2023, then increased by 15.88% to $2.6 million in 2024, then crashed by 35.51% to $1.6 million in 2025.
- Its Prepaid Assets was $1.6 million in Q3 2025, compared to $1.3 million in Q2 2025 and $1.9 million in Q1 2025.